Specific mutation screening of TP53 gene by low-density DNA microarray

被引:0
|
作者
Rangel-Lopez, Angelica [1 ,2 ,3 ]
Mendez-Tenorio, Alfonso [3 ]
Beattie, Kenneth L. [4 ]
Maldonado, Rogelio [3 ]
Mendoza, Patricia [1 ]
Vazquez, Guelaguetza [1 ]
Perez-Plasencia, Carlos [5 ]
Sanchez, Martha [2 ]
Navarro, Guillermo [6 ]
Salcedo, Mauricio [1 ]
机构
[1] Hosp Oncol, Lab Oncol Genom, Unidad Invest Med Enfermedades Oncol, CMN Siglo XXI IMSS, Mexico City, DF, Mexico
[2] Hosp Especialidades Ctr Med La Raza, CMN Siglo XXI IMSS, Unidad Invest Med Enfermedades Nefrol, Mexico City, DF, Mexico
[3] Escuela Nacl Ciencias Biol, Lab Biotecnol & Bioinformat Genom, Ipn Mexico City, Mexico
[4] Amerigenics Inc, Crossville, TN USA
[5] Univ Nacl Autonoma Mexico, Inst Nacl Cancerol INCAN, Inst Invest Biomed, Unidad Invest Biomed Canc, Mexico City, DF, Mexico
[6] Univ Nacl Autonoma Mexico, Lab Organomet, Mexico City, DF, Mexico
关键词
oligonucleotide microarray; TP53; gene; point mutations;
D O I
暂无
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
TP53 is the most commonly mutated gene in human cancers. Approximately 90% of mutations in this gene are localized between domains encoding exons 5 to 8. The aim of this investigation was to examine the ability of the low density DNA microarray with the assistance of double tandem hybridization platform to characterize TP53 mutational hotspots in exons 5, 7, and 8 of the TP53. Nineteen capture probes specific to each potential mutation site were designed to hybridize to specific site. Virtual hybridization was used to predict the stability of hybridization of each capture probe with the target. Thirty-three DNA samples from different sources were analyzed for mutants in these exons. A total of 32 codon substitutions were found by DNA sequencing. 24 of them a showed a perfect correlation with the hybridization pattern system and DNA sequencing analysis of the regions scanned. Although in this work we directed our attention to some of the most representative mutations of the TP53 gene, the results suggest that this microarray system proved to be a rapid, reliable, and effective method for screening all the mutations in TP53 gene.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [1] Low density DNA microarray for detection of most frequent TP53 missense point mutations
    Angélica Rangel-López
    Rogelio Maldonado-Rodríguez
    Mauricio Salcedo-Vargas
    Juana Mercedes Espinosa-Lara
    Alfonso Méndez-Tenorio
    Kenneth L Beattie
    BMC Biotechnology, 5
  • [2] Mutation of the TP53 Gene in Placental Chorangiomatosis
    Luo, Ying
    FETAL AND PEDIATRIC PATHOLOGY, 2023, 42 (03) : 400 - 409
  • [3] Recurrent astrocytoma in a child: A report of cytogenetics and TP53 gene mutation screening
    Dam, A
    Fock, JM
    Hayes, VM
    Molenaar, WM
    van den Berg, E
    NEURO-ONCOLOGY, 2000, 2 (03) : 184 - 189
  • [4] Microarray analysis defines patterns of gene expression associated with mutation of TP53 in ovarian cancer
    Bernardini, M. Q.
    Lee, P.
    Baba, T.
    Whitaker, R. S.
    Murphy, S. K.
    Berchuck, A.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S84 - S84
  • [5] Germline mutation in the TP53 gene in uveal melanoma
    Nikola Hajkova
    Jan Hojny
    Kristyna Nemejcova
    Pavel Dundr
    Jan Ulrych
    Katerina Jirsova
    Johana Glezgova
    Ivana Ticha
    Scientific Reports, 8
  • [6] Germline mutation in the TP53 gene in uveal melanoma
    Hajkova, Nikola
    Hojny, Jan
    Nemejcova, Kristyna
    Dundr, Pavel
    Ulrych, Jan
    Jirsova, Katerina
    Glezgova, Johana
    Ticha, Ivana
    SCIENTIFIC REPORTS, 2018, 8
  • [7] Mutation and function of TP53
    Milner, J
    BRAIN PATHOLOGY, 2000, 10 (04) : 504 - 504
  • [8] The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
    Leroy, Bernard
    Fournier, Jean Louis
    Ishioka, Chikashi
    Monti, Paola
    Inga, Alberto
    Fronza, Gilberto
    Soussi, Thierry
    NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) : D962 - D969
  • [9] Specificity of TP53 mutation screening methods in cancerous tissues
    Breton, J
    Lechevrel, M
    Sichel, F
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (01) : 254 - 255
  • [10] TP53 mutation screening for patients at risk of myeloid malignancy
    Mukherjee, Devdeep
    Lawal, Rialnat A.
    Fitzhugh, Courtney D.
    Hourigan, Christopher S.
    Dillon, Laura W.
    LEUKEMIA, 2024, 38 (07) : 1604 - 1608